Quantcast

Latest Autoimmunity Stories

2014-05-29 16:26:10

VANCOUVER, May 29, 2014 /PRNewswire/ - Augurex Life Sciences Corp. announces a ground-breaking body of new data that will publish during the European League Against Rheumatism (EULAR) Annual Congress of Rheumatology taking place June 11-14 in Paris. Investigators will present the studies listed in the schedule below, which to date along with other publications, represent over 2000 patients evaluated with the 14-3-3 eta blood test. This follows the very recent publication of a study...

2014-05-27 15:56:29

JGU Evidence presented of the existence of a previously unknown form of lymphocyte that protects against intracellular infection The innate immune system recognizes infectious agents such as viruses and bacteria. A group of lymphocytes known as "innate lymphoid cells" or ILCs plays a central role in the defense of the human body against infective agents. Professor Andreas Diefenbach of the Research Center Immunology at the Mainz University Medical Center, working in collaboration with...

Surprising Similarities In The Way Immune System Defenders Bind To Disease-causing Invaders
2014-05-27 03:50:47

By Glenn Roberts Jr., Stanford University A study led by researchers at Stanford's School of Medicine reveals how T cells, the immune system's foot soldiers, respond to an enormous number of potential health threats. X-ray studies at the Department of Energy's SLAC National Accelerator Laboratory, combined with Stanford biological studies and computational analysis, revealed remarkable similarities in the structure of binding sites, which allow a given T cell to recognize many...

2014-05-27 08:28:58

SEATTLE and SAN FRANCISCO, May 27, 2014 /PRNewswire/ -- Immune Design, a clinical-stage immunotherapy company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced the application of its GLAAS(TM)( )discovery platform in the Phase 1 clinical trial of MEDI7510, an investigational agent for respiratory syncytial virus (RSV) being developed by MedImmune, the global biologics research and development arm of AstraZeneca....

2014-05-21 08:29:06

First Demonstration of Safety and Tolerability of Physiocrines SAN DIEGO, May 21, 2014 /PRNewswire/ -- aTyr Pharma, an innovative rare disease therapeutics enterprise, announced today completion of Phase 1 for its lead program, Resokine IV. Our study, which marked the first ever administration of a Physiocrine to humans, was conducted in healthy male and female subjects in the European Union to assess the safety and tolerability of Resokine IV. aTyr Pharma is developing Resokine IV...

2014-05-17 23:00:41

The Autoimmunity Bible & Norton Protocol is a new method created by Julia Liu that claims to help people treat autoimmune disease permanently at their home. The full review on the website hynguyenblog.com shows whether this method is helpful or not. Seattle, WA (PRWEB) May 17, 2014 The Autoimmunity Bible & Norton Protocol is the newest guide designed by Julia Liu that promises to help people treat autoimmune diseases without using drugs or pills. This new method includes 261...

2014-05-13 11:31:45

Emory Health Sciences Carbohydrate-binding proteins fill in gaps in immune defenses Our bodies produce a family of proteins that recognize and kill bacteria whose carbohydrate coatings resemble those of our own cells too closely, scientists have discovered. Called galectins, these proteins recognize carbohydrates from a broad range of disease-causing bacteria, and could potentially be deployed as antibiotics to treat certain infections. The results are scheduled for publication in...

2014-05-13 08:31:54

SHENZHEN, China, May 13, 2014 /PRNewswire/ -- Chinese researchers have recently published new findings in Arthritis Research & Therapy, a top peer-reviewed journal in the field of systemic autoimmune rheumatic diseases, regarding the safety and effectiveness of umbilical cord (UC) derived mesenchymal stem cells (MSCs) in treating 40 patients with severe and refractory Systemic Lupus Erythematosus (SLE). The recent forty patient multi-center study was undertaken to assess the...

2014-05-12 12:30:40

Research Partnership Will Combine Efforts of Leading Lupus Experts With Berg's Award Winning Technology to Develop New, Targeted Therapies FRAMINGHAM, Mass. and CHARLESTON, S.C., May 12, 2014 /PRNewswire/ -- Berg and the Medical University of South Carolina today announced a strategic partnership, designed to identify new therapeutic pathways and potential biomarkers to treat Lupus, the autoimmune disease affecting one in every 2,000 people and one in every 250 young African American...

2014-05-10 16:21:04

NEW YORK, May 10, 2014 /PRNewswire/ -- S.L.E. Lupus Foundation's Young Leaders took Lupus Research to the Power of 10 in recognition of World Lupus Awareness Day May 10. A Flash Mob of volunteer dancers brought attention to lupus among hundreds of visitors to Union Square Park in Manhattan. Join our Power of 10 awareness program. Share this link (www.powerof10.lupusny.org) with 10 people, and ask those 10 to do the same. The goal is for 1 million people to learn about lupus and...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related